Navigation Links
PetScreen Supports Morris Animal Foundation Canine Cancer Campaign; Co-Sponsors Two Canine Cancer Studies
Date:11/1/2007

DENVER, Nov. 1 /PRNewswire/ -- PetScreen, http://www.pet-screen.com, a U.K.-based company providing screening for cancer and other diseases attacking pets, has made a generous donation to Morris Animal Foundation (MAF) in the nonprofit's global effort to cure canine cancer. PetScreen has provided financial co-sponsorship for two important canine cancer research studies. The MAF Canine Cancer Campaign is seeking to prevent canine cancer, while immediately seeking treatment advancements to help dogs suffering from cancer today. Learn more and donate to the campaign at http://www.CureCanineCancer.org or http://www.MorrisAnimalFoundation.org.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040701/LAMAFLOGO

http://www.newscom.com/cgi-bin/prnh/20070417/LATU030LOGO)

"We are delighted to be able to support the Morris Animal Foundation in their efforts to combat cancer in dogs," states Graeme Radcliff, founder of PetScreen. "Having suffered the loss of three of our family's precious dogs to cancer, PetScreen represents the culmination of a personal battle for me and my wife, Eileen, to help fight this disease, which is all too prevalent in the canine world." Mr. Radcliff says the donation was made in the name of his family's three current dogs: Libbi -- chocolate Labrador, Saskia -- German shepherd and Hugo -- Irish water spaniel. See PetScreen photos http://www.pet-screen.com/web/petscr/index.cfm?s=9&dir=5133.

Dr. Kevin Slater, chief executive of PetScreen, comments on the company's canine cancer efforts. "Having developed a screening test for canine lymphoma, we are now working hard to refine its application to the benefit of dogs, owners and their veterinarians," says Dr. Slater. "Over the last couple of years, we have learned a great deal about applying new technology to improve pet health. Every day we are striving to learn more. This knowledge is helping us refine and provide a range of advanced tests for cancer and other diseases plaguing pets around the world."

"Morris Animal Foundation greatly appreciates PetScreen's donation to help us address the leading cause of death in dogs over the age of 2, says Dr. Patricia Olson, president and CEO of MAF. "We hope other companies in the U.S., the U.K. and around the world will step up and help us fund this valuable research."

Dr. Olson adds that the very same cancer research breakthroughs benefiting dogs are having direct benefit to humans suffering from cancer. "Here again, the dog is proving itself to be man's best friend," comments Dr. Olson.

About Morris Animal Foundation: Morris Animal Foundation, established in 1948, is dedicated to funding research that protects, treats and cures companion animals and wildlife. MAF has been at the forefront of funding breakthrough research studies benefiting animals in some 100 countries, spanning all seven continents on earth. MAF has its headquarters in Denver, Colorado. The Foundation has funded nearly 1,400 humane animal health studies with funds totaling more than $51 million. One hundred percent of annual, unrestricted contributions support animal health programs. For more information, call (800) 243-2345, or visit http://www.MorrisAnimalFoundation.org.

Media Contact: Michael Burke

mburke@MorrisAnimalFoundation.org

(303) 790-2345


'/>"/>
SOURCE Morris Animal Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Vitamin E supports Female Hearts
2. Injection supports Heart Devices
3. Study supports vegetable diet
4. Study supports century-old cancer theory
5. Google Supports Indians Novel Literacy Drive
6. Actor Anil Kapoor Supports Birth Registration Cause
7. AMA Supports Tax Penalty for Uninsured Americans
8. Church Supports HIV Test Before Marriage
9. EHRVA Supports EHR Product Certification
10. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
11. Bush Supports Restriction to ‘Morning–After’ Pll
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... , ... May 31, 2016 , ... WaterField Designs, an ... professionals, announces the waxed-canvas and leather Duo Dopp Kit , the ideal gift ... or ballistic nylon, the Duo is smartly designed for Dad’s grooming routine. ...
(Date:5/31/2016)... CA (PRWEB) , ... May 31, 2016 , ... Interest ... a primary screening tool and as an orthogonal tool for RNAi hit validation. A ... functional and specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed ...
(Date:5/31/2016)... ... 2016 , ... MinerEye today announced that it has been ... by Gartner1 Inc. , Each year, Gartner identifies new Cool Vendors in key ... and their products and services. , According to Gartner, “Gartner's Cool Vendors in ...
(Date:5/31/2016)... ... May 31, 2016 , ... CURE Media Group ... cancer, has added Cancer and Careers to its Advocacy Spotlight ... on continuing successful careers while fighting cancer. , As partners, both organizations will ...
(Date:5/30/2016)... , ... May 30, 2016 , ... ... businesses, announced today the publication of an original infographic, " Health Benefits Reimbursement ... insurance professionals understand how Zane Benefits complies with various federal regulations and reforms. ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016   Change Healthcare , ... network solutions and technology-enabled services designed to ... into a strategic channel partnership with SourceMed, ... solutions and revenue cycle management services that ... rehabilitation clinics to optimize revenue, operational efficiency ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
Breaking Medicine Technology: